TP53 Allelic State Reprograms Human Blood Stem Cells, Study Finds

Consortium: Graz / EMBL Research Team · Finding: TP53 Allelic State Reprograms Human HSPCs · Publication: Leukemia · Date: August 18, 2026 Summary A peer-reviewed study used CRISPR/Cas9 and AAV6-mediated homology-directed repair to construct defined monoallelic and biallelic TP53 lesions in human cord-blood CD34+ hematopoietic…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *